Increased expression and activity of MMP-9 in chronic rhinosinusitis with nasal polyposis;Aumento de expresión y actividad de MMP-9 en rinosinusitis crónica con poliposis nasal

Acta Otorrinolaringologica Espanola

Volumn 59, Issue 9, 2008, Pages 444-447

  Eisenberg, Gustavo ^a   Pradillo, Jesús ^b   Plaza, Guillermo ^a   Lizasoain, Ignacio ^b   Moro, María A ^b  

^a HOSPITAL UNIVERSITARIO DE FUENLABRADA   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

MMP 2; MMP 9; Nasal polyposis

Indexed keywords

GELATINASE A; GELATINASE B;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; NOSE POLYP; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; RHINOSINUSITIS; TISSUE REGENERATION;

EID: 56049112339     PISSN: 00016519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-6519(08)75116-1     Document Type: Article

References (15)

1. Benítez P, Mullol J, Montserrat JR. Poliposis nasal. Ponencia oficial de la SEORL y PCF 2005. Mullol J, Montserrat JR, editores. Rinitis, rinosinusitis, poliposis nasal. Badalona: Euromedice; 2005. p. 755-74.
2. Kostamo K, Tervahartiala T, Sorsa T, Richardson M, Toskala E. Metalloproteinase function in chronic rhinosinusitis with nasal polyposis. Laryngoscope. 2007;117:638-43.
3. Rehl RM, Balla AA, Cabay RJ, Hearp ML, Pytynia KB, Joe SA. Mucosal remodeling in chronic rhinosinusitis. Am J Rhinol. 2007;21:651-7.
4. Lechapt-Zalcman E, Escudier E. Implication of extracellular matrix metalloproteinases in the course of chronic inflammatory airway diseases. Morphologie. 2000;84:45-9.
5. Watelet JB, Bachert C, Claeys C, Van Cauwenberge P. Matrix metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1: expression in chronic sinusitis vs nasal polyposis. Allergy. 2004;59:54-60.
6. De S, Fenton JE, Jones AS. Matrix metalloproteinases and their inhibitors in non-neoplastic otorhinolaryngological disease. J Laryngol Otol. 2005;119:436-42.
7. Parks WC, Shapiro SD. Matrix metalloproteinases in lung biology. Respir Res. 2001;2:10-9.
8. Gueders MM, Foidart JM, Noel A, Cataldo DD. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases. Eur J Pharmacol. 2006;533:133-44.
9. Lechapt-Zalcman E, Coste A, d'Ortho MP, Frisdal E, Harf A, Lafuma C, et al. Increased expression of matrix metalloproteinase-9 in nasal polyps. J Pathol. 2001;193:233-41.
10. Chen YS, Langhammer T, Westhofen M, Lorenzen J. Relationship between matrix metalloproteinases MMP-2, MMP-9 tissue inhibitor of matrix metalloproteinases-1 and IL-5, IL-8 in nasal polyps. Allergy. 2007;62:66-72.
11. Bhandari A, Takeuchi K, Suzuki S, Harada T, Hayashi S, Imanaka-Yoshida K, et al. Increased expression of matrix metalloproteinase-2 in nasal polyps. Acta Otolaryngol. 2004;124:1165-70.
12. Fokkens W, Lund V, Bachert C, Clement P, Hellings P, Holstrom M, et al. EAACI position paper on rhinosinusitis and nasal polyps. Executive summary. Allergy. 2005;60:583-601.
13. Caso J, Pradillo J, Hurtado O, Lorenzo P, Moro MA, Lizasoain I. Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation. 2007;115:1599-608.
14. Lildholdt T, Rundcrantz H, Bende M, Larsen K. Glucocorticoid treatment for nasal polyps. The use of topical budesonide powder, intramuscular betamethasone, and surgical treatment. Arch Otolaryngol Head Neck Surg. 1997;123:595-600.
15. Watelet JB, Demetter P, Claeys C, Van Cauwenberge P, Cuvelier C, Bachert C. Neutrophil-derived metalloproteinase-9 predicts healing quality after sinus surgery. Laryngoscope. 2005;115:56-61.